Zheng Qi, Liu Lei, Liu Haolong, Zheng Hong, Sun Hao, Ji Jing, Sun Yaqin, Yang Tao, Zhao Hui, Qi Fang, Li Kangning, Li Junling, Zhang Nan, Fan Yongping, Wang Lei
School of Traditional Chinese Medicine, Beijing Key Lab of TCM Collateral Disease Theory Research, Capital Medical University, Beijing, China.
Oncology Department, Guang An Men Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Front Pharmacol. 2019 Jul 17;10:796. doi: 10.3389/fphar.2019.00796. eCollection 2019.
Axonal damage is recognized as an important pathological feature in the chronic progressive neurological disorder multiple sclerosis (MS). Promoting axonal regeneration is a critical strategy for the treatment of MS. Our clinical and experimental studies have shown that the Bu Shen Yi Sui formula (BSYS) promotes axonal regeneration in MS and experimental autoimmune encephalomyelitis (EAE), an animal model of MS, but the exact mechanism has not been thoroughly elucidated to date. In this study, we investigated the effects of BSYS and its two decomposed formulas-the Bu Shen formula (BS) and the Hua Tan Huo Xue formula (HTHX)-on brain-derived neurotrophic factor (BDNF)/TrkB and related signaling pathways to explore the mechanism by which axonal regeneration is promoted and . Damaged SH-SY5Y cells incubated with low serum were treated with BSYS-, BS-, and HTHX-containing serum, and EAE mice induced by the myelin oligodendrocyte glycoprotein (MOG) peptide were treated with BSYS. The results showed that the BSYS-containing serum markedly increased cell viability and increased the levels of growth associated protein (GAP)-43, phosphorylated (p)-cAMP-response element binding protein (CREB), BDNF, TrkB, and p-PI3K. The BS and HTHX treatments also induced the protein expression of GAP-43 and p-extracellular signal-regulated kinase (ERK) in the cells. Furthermore, the effects of BSYS on cell viability, GAP-43, p-CREB, and neurite outgrowth were clearly inhibited by LY294002, a specific antagonist of the PI3K signaling pathways. The addition of U0126 and U73122, antagonists of the ERK and PLCγ pathway, respectively, significantly inhibited cell viability and GAP-43 protein expression. Moreover, BSYS treatment significantly increased the expression of the 68-, 160-, and 200-kDa neurofilaments (NFs) of proteins and the BDNF, TrkB, PI3K, and Akt mRNA and proteins in the brain or spinal cord of mice at different stages. These results indicated that BSYS promotes nerve regeneration, and its mechanism is mainly related to the upregulation of the BDNF/TrkB and PI3K/Akt signaling pathways. BS and HTHX also promoted nerve regeneration, and this effect involved the ERK pathway.
轴突损伤被认为是慢性进行性神经疾病多发性硬化症(MS)的一个重要病理特征。促进轴突再生是治疗MS的关键策略。我们的临床和实验研究表明,补肾益髓方(BSYS)可促进MS及实验性自身免疫性脑脊髓炎(EAE,MS的动物模型)中的轴突再生,但确切机制迄今尚未完全阐明。在本研究中,我们研究了BSYS及其两个分解方——补肾方(BS)和化痰活血方(HTHX)——对脑源性神经营养因子(BDNF)/酪氨酸激酶受体B(TrkB)及相关信号通路的影响,以探讨其促进轴突再生的机制。用含BSYS、BS和HTHX的血清处理在低血清中培养的受损SH-SY5Y细胞,并用BSYS处理由髓鞘少突胶质细胞糖蛋白(MOG)肽诱导的EAE小鼠。结果显示,含BSYS的血清显著提高细胞活力,并增加生长相关蛋白(GAP)-43、磷酸化(p)-环磷腺苷反应元件结合蛋白(CREB)、BDNF、TrkB和p-磷脂酰肌醇-3-激酶(PI3K)的水平。BS和HTHX处理也诱导细胞中GAP-43和p-细胞外信号调节激酶(ERK)的蛋白表达。此外,PI3K信号通路的特异性拮抗剂LY294002明显抑制了BSYS对细胞活力、GAP-43、p-CREB和神经突生长的影响。分别加入ERK和磷脂酶Cγ(PLCγ)通路的拮抗剂U0126和U73122,显著抑制了细胞活力和GAP-43蛋白表达。此外,BSYS处理显著增加了不同阶段小鼠脑或脊髓中68 kDa、160 kDa和200 kDa神经丝(NF)蛋白以及BDNF、TrkB、PI3K和Akt的mRNA和蛋白表达。这些结果表明,BSYS促进神经再生,其机制主要与上调BDNF/TrkB和PI3K/Akt信号通路有关。BS和HTHX也促进神经再生,且这种作用涉及ERK通路。